| JTS1900029 | 雷莫芦单抗注射液 | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2019-06-25 | Lilly France | Lilly France | Certificate Issued | 2019-07-25 | view |
| JYSB2000503 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-10-13 | Lilly France | Lilly France | Certificate Issued | 2020-11-26 | view |
| JYSZ1200092 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | License Renew | 2012-12-22 | Lilly France | Lilly France | Certificate Issued | 2013-12-17 | view |
| JYSB2000167 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-05-09 | Lilly France | Lilly France | Certificate Issued | 2021-03-25 | view |
| JYSB1900174 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2019-07-18 | Lilly France | Lilly France | Certificate Issued | 2019-11-01 | view |
| JYSB1200155 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2012-06-19 | Lilly France | Lilly France | Approval Completed-Pending Certificated | 2014-12-29 | view |
| JYSB1300125 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2013-06-03 | Lilly France | Lilly France | Certificate Issued | 2015-01-26 | view |
| JYSB2000438 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-09-08 | Lilly France | Lilly France | Filed | 2020-09-18 | view |
| JYSB2000255 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-19 | view |
| JYSB2000168 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-05-08 | Lilly France | Lilly France | Certificate Issued | 2021-03-25 | view |
| JYSB1900173 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2019-07-18 | Lilly France | Lilly France | Certificate Issued | 2019-11-01 | view |
| JYSB1200154 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2012-06-19 | Lilly France | Lilly France | Approval Completed-Pending Certificated | 2014-12-29 | view |
| JYSB2000258 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-19 | view |
| JYSB1700083 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2017-04-27 | Lilly France | Lilly France | In Review | 2017-04-26 | view |
| JYSB1300124 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2013-06-03 | Lilly France | Lilly France | Certificate Issued | 2015-01-26 | view |
| JYSB1400034 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2014-02-14 | Lilly France | Lilly France | Certificate Issued | 2015-06-02 | view |
| JYSB2000472 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-09-27 | Lilly France | Lilly France | Filed | 2020-10-19 | view |
| JYSZ1900060 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | License Renew | 2019-11-21 | Lilly France | Lilly France | Certificate Issued | 2020-05-21 | view |
| JYSB2000169 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-05-08 | Lilly France | Lilly France | In Review | 2020-05-07 | view |
| JYSB2000257 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-19 | view |
